NASDAQ: IMMXImmix Biopharma Inc Stock Ownership - Who owns Immix Biopharma?
Insider buying vs selling
Have Immix Biopharma Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jason Hsu | Director | 2023-12-11 | 31,000 | $4.67 | $144.89kBuy |
| Jason Hsu | Director | 2023-12-08 | 25,000 | $4.88 | $122.03kBuy |
| Jason Hsu | Director | 2023-09-15 | 7,000 | $2.49 | $17.40kBuy |
| Carey Ng | Director | 2023-09-14 | 10,000 | $2.58 | $25.76kBuy |
| Jason Hsu | Director | 2023-09-14 | 10,000 | $2.58 | $25.77kBuy |
| Helen C. Adams | Director | 2023-09-12 | 13,000 | $2.96 | $38.49kBuy |
| Jason Hsu | Director | 2023-09-12 | 30,000 | $2.83 | $84.87kBuy |
| Jason Hsu | Director | 2023-09-11 | 25,000 | $2.89 | $72.28kBuy |
| Jason Hsu | Director | 2023-09-08 | 10,000 | $2.53 | $25.32kBuy |
| Melissa Jane Buchan | Director | 2023-09-07 | 20,000 | $2.46 | $49.22kBuy |
IMMX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when IMMX insiders and whales buy or sell their stock.
IMMX Shareholders
What type of owners hold Immix Biopharma Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Yekaterina Chudnovsky | 12.28% | 3,241,076 | $6.87M | Insider |
| Carey Ng | 3.92% | 1,035,221 | $2.19M | Insider |
| Ilya M. Rachman | 3.44% | 907,700 | $1.92M | Insider |
| Vladimir P. Torchilin | 3.43% | 905,200 | $1.92M | Insider |
| Sean Senn | 3.41% | 899,800 | $1.91M | Insider |
| Jason Hsu | 3.27% | 863,000 | $1.83M | Insider |
| Gabriel S. Morris | 1.24% | 328,019 | $695.40k | Insider |
| Vanguard Group Inc | 0.61% | 160,398 | $340.04k | Institution |
| Eam Investors LLC | 0.39% | 102,661 | $217.64k | Institution |
| Private Advisor Group LLC | 0.38% | 99,775 | $211.52k | Institution |
IMMX vs Biotech Stocks
Immix Biopharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.